Monogram Biosciences

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Monogram Biosciences, Inc.
Wholly owned subsidiary of LabCorp
Industry Biotechnology
Headquarters South San Francisco, California
Products PhenoSense, PhenoSense GT, Trofile, GeneSeq, VeraTag, HERmark
Number of employees
379 (2008)
Parent LabCorp

Monogram Biosciences Inc. (formerly ViroLogic Inc.), a wholly owned subsidiary of LabCorp, is an international biotechnology laboratory located in South San Francisco, California, USA. Monogram develops and markets assays to help guide and improve the treatment of infectious diseases (including HIV and Hepatitis) and cancer.

Virologic was founded in 1996 by Daniel Capon, Ph.D., Martin Goldstein and Robert S. Capon. The company went public (NASDAQ: VLGC) in 2000.

Monogram was acquired by Laboratory Corporation of America in June 2009.[1]


External links[edit]

  • Official website
  • Baseline HIV Type 1 Coreceptor Tropism Predicts Disease Progression [1]
  • Four Studies Affirm Significance Of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay [2]
  • Accuracy of Monogram's Trofile Assay in Determining Tropism and New Tropism Assays in Development [3]
  • Trofile Bests SensiTrop as Most Reliable Tropism Test [4]
  • Monogram Biosciences teams up with Pfizer for HIV treatment [5]
  • Monogram Biosciences Launches New "Trofile" HIV Co-receptor Tropism Test to Select Patients Eligible to User CCR5 Antagonist Maraviroc (Selzentry) [6]
  • 2007 HIV Treatment Guidelines [7]
  • All About HIV Tropism [8]